Literature DB >> 476301

Prolonged hematopoiesis in a primate bone marrow culture system: characteristics of stem cell production and the hematopoietic microenvironment.

M A Moore, A P Sheridan, T D Allen, T M Dexter.   

Abstract

Maintenance of myelopoiesis and pluripotential stem cell production for prolonged periods in vitro hitherto has been limited to mouse bone marrow culture. In an effort to adapt the system for use in higher species, particularly in human and non-human primates, studies were undertaken using the prosimian species, Tupaia glis (tree shrew). In a number of experiments the duration of sustained normal hematopoiesis observed in cultures of this species, following a single inoculum of 5 X 10(6)--10(7) bone marrow cells, with or without addition of fresh allogeneic bone marrow exceeded 1 yr. Analysis of suspension cells obtained by weekly demidepopulation of such cultures revealed production of CFU-C, differentiating neutrophils, and basophils at high levels. Direct comparison with murine cultures indicated that in both species a complex series of cellular interactions takes place within an adherent environment of marrow-derived endothelial cells, macrophages, and fat-containing cells. Certain functional and ultrastructural features served to distinguish murine from Tupaia marrow cultures, and the prolonged duration of in vitro hematopoiesis in the latter species could be attributed to a regenerative capacity possessed by its adherent hematopoietic microenvironment. The availability of this primate marrow culture system should facilitate studies of hematopoiesis, viral leukemogenesis, and transplantation biology, which have more direct relevance to man than that provided by the existing murine system.

Entities:  

Mesh:

Year:  1979        PMID: 476301

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  12 in total

1.  Rapid medium perfusion rate significantly increases the productivity and longevity of human bone marrow cultures.

Authors:  R M Schwartz; B O Palsson; S G Emerson
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-01       Impact factor: 11.205

Review 2.  Bloodlines of haematopoietic stem cell research in Japan.

Authors:  Hideo Ema; Hiromitsu Nakauchi
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2008-06-27       Impact factor: 6.237

Review 3.  Progress in bone marrow transplantation in man.

Authors:  R P Gale
Journal:  Surv Immunol Res       Date:  1982

4.  Myelo-lymphopoiesis in long-term bone marrow culture.

Authors:  H G Mergenthaler
Journal:  Klin Wochenschr       Date:  1985-04-15

5.  Osteoblastic adherence regulates hematopoietic stem cell self-renewal and differentiation: a conceptional in vitro and in vivo study.

Authors:  Teruyuki Kajiume; Yumi Kawahara; Louis Yuge; Masao Kobayashi
Journal:  Stem Cell Investig       Date:  2021-10-11

6.  Phenomenon of formation of giant fat-containing cells in human bone marrow cultures induced by human serum factor: normal and leukemic patterns.

Authors:  I A Svet-Moldavskaya; S N Zinzar; G J Svet-Moldavsky; Z Arlin; C Vergara; B Koziner; B D Clarkson; J F Holland
Journal:  Proc Natl Acad Sci U S A       Date:  1983-08       Impact factor: 11.205

7.  A novel method for long term bone marrow culture and genetic modification of murine neutrophils via retroviral transduction.

Authors:  Rachel L Zemans; Natalie Briones; Scott K Young; Kenneth C Malcolm; Yosef Refaeli; Gregory P Downey; G Scott Worthen
Journal:  J Immunol Methods       Date:  2008-11-14       Impact factor: 2.303

8.  Long-term bone marrow culture systems: normal and cyclic hematopoietic dogs.

Authors:  Z S Al-Lebban; R D Lange; J B Jones; C D Lothrop
Journal:  Can J Vet Res       Date:  1987-04       Impact factor: 1.310

9.  Long-term culture of human bone marrow cells.

Authors:  S Gartner; H S Kaplan
Journal:  Proc Natl Acad Sci U S A       Date:  1980-08       Impact factor: 11.205

Review 10.  Ex vivo expansion of cord blood.

Authors:  S S Kelly; C B S Sola; M de Lima; E Shpall
Journal:  Bone Marrow Transplant       Date:  2009-10-05       Impact factor: 5.483

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.